Fig. 6
From: Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting
Total tumor cellularity (A) and bulk tumor flow (B) tend to decline over the course of NAT. Patients who achieved a pCR are shown in red in A and B. Significant differences in the relative change in cellularity from baseline C were observed between patients who achieved pCR and those who did not achieve pCR at all three MRIs following baseline. Significant differences in the relative change in bulk tumor flow from baseline D were observed between patients who achieved pCR and those who did not achieve pCR at the third and fourth MRI (*p < 0.05; **p < 0.01; ***p < 0.001)